Phospholipase D2 Antikörper (Middle Region)

Produktnummer ABIN927421

Dieses Kaninchen Polyklonal-Antikörper erkennt spezifisch Phospholipase D2 in WB. Er zeigt eine Reaktivität gegenüber Human, Ratte und Rind (Kuh).

Kurzübersicht für Phospholipase D2 Antikörper (Middle Region) (ABIN927421)

Target: Phospholipase D2 (PLD2)

Reaktivität: Human, Ratte, Rind (Kuh)

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser Phospholipase D2 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Produktdetails anti-Phospholipase D2 Antikörper

Bindungsspezifität: Middle Region

Kreuzreaktivität: Ratte (Rattus), Rind (Kuh)

Aufreinigung: Purified

Immunogen: PLD2 antibody was raised in rabbit using the middle region of PLD2 as the immunogen

Anwendungsinformationen

Applikationshinweise: WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator.

Kommentare:

PLD2 Blocking Peptide, (ABIN937433), is also available for use as a blocking control in assays to test for specificity of this PLD2 antibody

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Konzentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Handhabung: Avoid repeated freeze/thaw cycles.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Details zu Phospholipase D2

Target: Phospholipase D2 (PLD2)

Andere Bezeichnung: PLD2

Hintergrund: Phosphatidylcholine (PC)-specific phospholipases D (PLDs, EC 3.1.4.4) catalyze the hydrolysis of PC to produce phosphatidic acid and choline. Activation of PC-specific PLDs occurs as a consequence of agonist stimulation of both tyrosine kinase and G protein-coupled receptors. PC-specific PLDs have been proposed to function in regulated secretion, cytoskeletal reorganization, transcriptional regulation, and cell cycle control. Synonyms: Polyclonal PLD2 antibody, Anti-PLD2 antibody, phospholipase D2 antibody.

Pathways: RTK Signalweg, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Regulation of G-Protein Coupled Receptor Protein Signaling